Page 44 - David Ricks News Today

“The aggressive price cuts we’re announcing today should make a real difference for Americans with diabetes," said Lilly's Chair and CEO David Ricks.

Changes come as lawmakers and patient advocates pressure drugmakers to do something about soaring prices

Eli Lilly’s changes come as lawmakers and patient advocates pressure drugmakers to do something about soaring prices.

Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately-insured consumers at $35 per month.

NPR's Ailsa Chang talks with Eli Lilly CEO David Ricks about the company's move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.

Drugmaker Eli Lilly announced plans to slash prices on some older insulins, easing the burden on diabetics who need it to survive.

The announcement comes amid growing federal pressure to lower the cost of insulin prices.

Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap\u00a0out-of-pocket costs for privately insured consumers at $35 a month.

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions.

“The aggressive price cuts we’re announcing today should make a real difference for Americans with diabetes," said Lilly's Chair and CEO David Ricks.